These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22981388)

  • 41. Chemotherapy and altered fractionation in head-and-neck cancer: in regard to Staar et al., IJROBP 2001;50:1161-1171.
    Bentzen SM; Bernier J
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1423; author reply 1423-4. PubMed ID: 11955758
    [No Abstract]   [Full Text] [Related]  

  • 42. "Inject-a-gel" chemotherapy for advanced head and neck cancer.
    Burton A
    Lancet Oncol; 2002 Oct; 3(10):583. PubMed ID: 12372707
    [No Abstract]   [Full Text] [Related]  

  • 43. Concurrent chemotherapy and radiation for locally advanced squamous cell cancers: what is the schedule of choice?
    Schornagel JH; Verheij M; Bartelink H
    Curr Oncol Rep; 2001 Jan; 3(1):1-2. PubMed ID: 11123863
    [No Abstract]   [Full Text] [Related]  

  • 44. [Induction chemotherapy in locally advanced head and neck cancer? No].
    Tribius S; Petersen C
    Dtsch Med Wochenschr; 2014 Oct; 139(41):2081. PubMed ID: 25268209
    [No Abstract]   [Full Text] [Related]  

  • 45. Role of Induction Chemotherapy Prior to Chemoradiation in Head and Neck Squamous Cell Cancer-Systematic Review and Meta-analysis.
    Vidal L; Ben Aharon I; Limon D; Cohen E; Popovtzer A
    Cancer J; 2017; 23(2):79-83. PubMed ID: 28410291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Induction chemotherapy in locally advanced head and neck cancer? Yes].
    Knecht R; Busch CJ; Schafhausen P
    Dtsch Med Wochenschr; 2014 Oct; 139(41):2080. PubMed ID: 25268208
    [No Abstract]   [Full Text] [Related]  

  • 47. Altered fractionation and combined radio-chemotherapy approaches: pioneering new opportunities in head and neck oncology.
    Bernier J; Bentzen SM
    Eur J Cancer; 2003 Mar; 39(5):560-71. PubMed ID: 12628834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The viewpoint of the radiotherapy oncologist].
    Corvò R
    Tumori; 2008; 94(4):suppl 30-3. PubMed ID: 18822715
    [No Abstract]   [Full Text] [Related]  

  • 49. Meaningful Questions in "Organ Preservation" - Past, Present, and Future.
    Posner M; Gupta V
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26681801
    [No Abstract]   [Full Text] [Related]  

  • 50. Induction chemotherapy in squamous cell carcinoma of the head and neck: saved by the bell?
    Specenier P
    Oral Oncol; 2015 Feb; 51(2):e5-7. PubMed ID: 25497106
    [No Abstract]   [Full Text] [Related]  

  • 51. [Induction and Palliative Chemotherapy for Head and Neck Cancer].
    Honma Y
    Gan To Kagaku Ryoho; 2019 Jan; 46(1):14-20. PubMed ID: 30765635
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postoperative radiotherapy with simultaneous chemotherapy in high-risk squamous cell carcinoma of the head and neck: a novel standard that opens new questions.
    Giralt J; Bernier J
    Clin Transl Oncol; 2005 Jun; 7(5):181-2. PubMed ID: 15960928
    [No Abstract]   [Full Text] [Related]  

  • 53. Synchronous chemoradiation for squamous carcinomas.
    Tobias JS; Ball D
    BMJ; 2001 Apr; 322(7291):876-8. PubMed ID: 11302885
    [No Abstract]   [Full Text] [Related]  

  • 54. The current role of systemic chemotherapy in the primary treatment of head and neck cancer.
    Busch CJ; Tribius S; Schafhausen P; Knecht R
    Cancer Treat Rev; 2015 Mar; 41(3):217-21. PubMed ID: 25687982
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Meta-analyses in head and neck squamous cell carcinoma. What is the role of chemotherapy?
    Bourhis J; Pignon JP
    Hematol Oncol Clin North Am; 1999 Aug; 13(4):769-75, vii. PubMed ID: 10494512
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction chemotherapy for head and neck squamous cell carcinoma.
    T Parsons J; D Greene B
    Oral Oncol; 2016 Jul; 58():e12. PubMed ID: 27256109
    [No Abstract]   [Full Text] [Related]  

  • 57. Role of chemotherapy in the multidisciplinary approach to advanced head and neck cancer: potentials and problems.
    Ervin TJ; Karp DD; Weichselbaum RR; Posner MR; Fabian RL; Miller D
    Ann Otol Rhinol Laryngol; 1981; 90(5 Pt 1):506-11. PubMed ID: 7030176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modeling the contribution of synchronous chemotherapy to the rate of grade 3 and 4 mucositis in locally advanced squamous cell carcinoma of the head and neck.
    Hartley A; Sanghera P; Glaholm J; Fowler JF
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):315; author reply 315. PubMed ID: 19695442
    [No Abstract]   [Full Text] [Related]  

  • 59. Does DeCIDE give a decisive answer against induction chemotherapy in head and neck cancers?
    Chakraborty S; Patil VM
    J Clin Oncol; 2015 Mar; 33(8):967. PubMed ID: 25667296
    [No Abstract]   [Full Text] [Related]  

  • 60. Quality assurance of radiation therapy for head and neck cancer patients treated in DAHANCA 10 randomized trial.
    Hansen CR; Johansen J; Kristensen CA; Smulders B; Andersen LJ; Samsøe E; Andersen E; Petersen JB; Overgaard J; Grau C
    Acta Oncol; 2015; 54(9):1669-73. PubMed ID: 26206516
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.